Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Flow cytometry interference in patients treated with tafasitamab: Unraveling the diagnostic maze

Published:2024-01 Issue:1 Volume:8 Page:
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:HemaSphere

Author:

Proost Lisa¹,Lambrecht Stijn¹,Hofmans Mattias¹,De Vriendt Ciel²,Speeckaert Marijn³,Bonroy Carolien¹,Denys Barbara¹,De Bruyne Sander¹⁴

Affiliation:

1. Department of Laboratory Medicine Ghent University Hospital Ghent Belgium

2. Department of Hematology Ghent University Hospital Ghent Belgium

3. Department of Nephrology Ghent University Hospital Ghent Belgium

4. Department of Transfusion Medicine Ghent University Hospital Ghent Belgium

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hem3.39

Reference18 articles.

1. New Directions for Mantle Cell Lymphoma in 2022

2. Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

3. Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma

4. Tafasitamab mediates killing of B-cell non-Hodgkin’s lymphoma in combination with γδ T cell or allogeneic NK cell therapy

5. Assessment of Measurable Residual Disease (MRD) in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Among U.S. Community Hematologists/ Oncologists (cH/O)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP